Impact of prior solid tumor on outcomes of hematopoietic stem cell transplantation for hematologic malignancies: a propensity score-matched study
Patients with hematologic diseases secondary to solid tumors showed no significant increase in overall transplantation risk. However, their adverse clinical characteristics and reduced long-term survival rates beyond 2 years post-transplantation, underscore the need to refine HCT-CI scoring and improve management strategies.
Authors
- S. feng
- R R Zhang
- Erlie Jiang (ORCID: https://orcid.org/0000-0003-0237-6063)
- Jieya Luo (ORCID: https://orcid.org/0000-0002-8761-7075)
- J J Wei
- M. Wang
- Weihua Zhai
- D L Yang
- Mingzhe Han
- Yunxia Zhou
- Qiaoling Ma
- Wenbin Cao
- Aiming Pang
- Xin Chen
- Yi He
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Clinical Research (US)
- Institute of Hematology & Blood Diseases Hospital (CN)
- Tianjin Medical University (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.3389/fimmu.2026.1727469
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City
- National Science and Technology Major Project